Inspira Technologies Achieves Patent Milestone in Japan
Inspira Technologies OXY B.H.N. Ltd. (NASDAQ: IINN), known for its pioneering advancements in life-support and diagnostic technologies, has reached an important milestone by securing a patent in Japan. The Japan Patent Office has granted Patent No. 7777598 for the innovative Convertible Dual Lumen Cannula device and its usage method. This achievement is significant as it solidifies the Company’s position within one of the leading markets for medical devices globally.
Exclusive Rights and Future Prospects
This new patent provides Inspira with exclusive commercial rights to its patented Dual Lumen Cannula technology in Japan until 2041. This development is a strategic addition to its existing U.S. Patent obtained earlier, creating a strong protective framework across two of the world’s largest healthcare economies. Such IP (intellectual property) protection is vital for Inspira’s plans regarding the standalone commercialization of its cannula, which is poised to become a high-demand disposable product in the market.
Innovative Design Benefits
The patented technology introduced by Inspira features a groundbreaking mechanism, enabling a single-lumen cannula to convert into a dual-lumen version after it has been inserted. This advancement is designed to allow healthcare professionals to switch configurations seamlessly during procedures, minimizing the need for further incisions. Such an approach can significantly lower infection rates, procedural complications, and can also lead to reduced costs for healthcare establishments compared to more traditional dual-lumen solutions.
Comments from Leadership
Dagi Ben-Noon, the CEO of Inspira Technologies, emphasized the substantial cost concerns associated with manufacturing traditional dual lumen cannulas. He noted, “Our patented convertible device introduces an economical solution for the market while potentially increasing patient safety and efficiency during procedures.” He also expressed confidence in the Company’s growth, highlighting the rigor of regulations in both Japan and the U.S., which bolster their business foundation despite challenging environments.
About Inspira Technologies
Inspira Technologies is a medical device company in the commercial stage, focusing on cutting-edge respiratory support and real-time blood monitoring solutions. The Company’s INSPIRA™ ART100 system holds FDA clearance for cardiopulmonary bypass procedures in the U.S. and ECMO (Extracorporeal Membrane Oxygenation) procedures internationally. The development of the INSPIRA ART500, a next-generation system that provides oxygenation while patients remain alert and capable of spontaneous breathing, further demonstrates Inspira’s commitment to innovation.
In addition to its core products, Inspira is also advancing the HYLA™ platform, which functions as a proprietary blood sensor for ongoing, non-invasive monitoring. With a growing portfolio of cleared devices, a solid intellectual property landscape, and a focus on refining operations, Inspira is increasingly recognized as a significant contender within the life-support and MedTech sectors.
Company Contact Information
Inspira Technologies – Media Relations
Email: info@inspirao2.com
Phone: +972-9-9664485
Frequently Asked Questions
What is the significance of the patent granted to Inspira Technologies?
The patent secures exclusive commercial rights for their innovative Convertible Dual Lumen Cannula in Japan until 2041, enhancing their market position.
How does the Convertible Dual Lumen Cannula work?
It allows a single-lumen cannula to convert into a dual-lumen type after insertion, enabling healthcare professionals to switch configurations without additional incisions.
What are the advantages of this new technology?
This design potentially reduces infection risks, procedural complications, and hospital costs when compared to traditional dual-lumen options, making it more efficient and affordable.
How does this patent impact Inspira's future?
This exclusive patent positions Inspira to effectively commercialize its cannula technology independently and strengthens its revenue streams in targeted healthcare markets.
What other products does Inspira Technologies offer?
In addition to the dual lumen cannula, Inspira offers the INSPIRA™ ART100 and is developing the INSPIRA ART500 for advanced respiratory support, alongside its HYLA™ blood sensor platform.
